GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $637,000 | -7.5% | 15,698 | -1.8% | 0.13% | -11.5% |
Q2 2017 | $689,000 | +17.8% | 15,990 | +15.3% | 0.15% | +13.8% |
Q1 2017 | $585,000 | +42.7% | 13,870 | +30.3% | 0.13% | +31.3% |
Q4 2016 | $410,000 | -9.7% | 10,645 | +1.1% | 0.10% | -11.6% |
Q3 2016 | $454,000 | +5.6% | 10,530 | +6.1% | 0.11% | +4.7% |
Q2 2016 | $430,000 | +14.7% | 9,920 | +7.2% | 0.11% | +21.6% |
Q1 2016 | $375,000 | +3.6% | 9,250 | +3.1% | 0.09% | -1.1% |
Q4 2015 | $362,000 | – | 8,972 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |